Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Erlotinib can cause excessive eyelash growth.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Trichoblastomas may mimic fetal skin development by having many Merkel cells, unlike adult skin.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The combination therapy was effective and well-tolerated, especially in young patients.

Baricitinib was effective in treating alopecia areata in two major trials.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

Metformin may help treat neuroendocrine tumors.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Recognizing minor skin lesions can help identify serious cancer syndromes.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

A man with a rare skin condition and a new gene mutation developed high calcium levels due to his treatment.